Background: As of March 30, 2022, the Food and Drug Administration now recommends follow up thyroid function testing (TFT) for children less than 4 years of age who have received IV iodinated contrast for imaging or procedures within 3 weeks of receiving contrast dye due to recent studies reporting subsequent thyroid dysfunction and the potential [...]

Case Presentation: Patient is a 73-year-old female with history of hypertension, chronic back pain on gabapentin, prior intravenous drug use, peripheral artery disease status post bilateral femoral endarterectomies with stenting on dual anti-platelet therapy who presented to the emergency department with right lower extremity pain. Patient was hemodynamically stable, alert and oriented. Shortly after undergoing [...]

Case Presentation: A 38-year-old woman with a history of Anxiety, Depression and Endometriosis presented for outpatient Magnetic Resonance Imaging (MRI) Pelvis with contrast for evaluation of chronic pelvic pain. Her medications included Alprazolam, Bupropion, Minoxidil, Sertraline and Ethinylestradiol/Levonorgestrel, with known allergies to Penicillin, Sulfa antibiotics and Shellfish. She fasted for four hours and took Alprazolam [...]

Case Presentation: 70 year old male veteran with Lung Adenocarcinoma, Chronic Obstructive Pulmonary Disease, and remote Mucosa Associated Lymphoid Tissue Lymphoma presents with nausea, diaphoresis, and shortness of breath following administration of intravenous Iodinated Contrast Media (ICM) obtained for a staging Computerized Tomography (CT) scan. The patient was afebrile, with sinus tachycardia at 120 beats [...]